is this gonna be another fuckin podcastc
November 28, 2023 at 3:57 PM
is this gonna be another fuckin podcastc
the bill received unanimous support in the house
is this good enough?
cancerletter.com/podcastc/202...
is this good enough?
cancerletter.com/podcastc/202...
Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I'm just asking him to show us.” - The Cancer Letter
On Dec. 19, the Mikaela Naylon Give Kids a Chance Act was blocked in the Senate by Sen. Bernie Sanders (I-VT) after receiving unanimous approval from the U.S. House of Representatives Dec. 1. This ep...
cancerletter.com
May 18, 2026 at 12:19 PM
the bill received unanimous support in the house
is this good enough?
cancerletter.com/podcastc/202...
is this good enough?
cancerletter.com/podcastc/202...
20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
cancerletter.com/podcastc/202...
cancerletter.com/podcastc/202...
20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect - The Cancer Letter
Two decades ago, the discovery of the EGFR mutation transformed lung cancer treatment. The finding led to dramatically improved survival rates and ushered in the era of precision medicine and molecula...
cancerletter.com
February 16, 2025 at 5:20 PM
20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
cancerletter.com/podcastc/202...
cancerletter.com/podcastc/202...
In the latest @cancerletter.com podcast, Dr. Frank McCormick @ucsanfrancisco.bsky.social discusses the wider implications of the recent FDA approved the RAS inhibitor, daraxonrasib
cancerletter.com/podcastc/202...
cancerletter.com/podcastc/202...
September 11, 2026 at 4:39 PM
In the latest @cancerletter.com podcast, Dr. Frank McCormick @ucsanfrancisco.bsky.social discusses the wider implications of the recent FDA approved the RAS inhibitor, daraxonrasib
cancerletter.com/podcastc/202...
cancerletter.com/podcastc/202...
Fred Hutch's Lynch, Sarah Cannon's Burris discuss NIH funding cuts in a top episode from TCL's "The Directors" series. (@fredhutch.org, @scri.com)
https://cancerletter.com/podcastc/20250516_1/
https://cancerletter.com/podcastc/20250516_1/
https://cancerletter.com/podcastc/20250516_1/
No description found
cancerletter.com
December 31, 2025 at 6:30 PM
Fred Hutch's Lynch, Sarah Cannon's Burris discuss NIH funding cuts in a top episode from TCL's "The Directors" series. (@fredhutch.org, @scri.com)
https://cancerletter.com/podcastc/20250516_1/
https://cancerletter.com/podcastc/20250516_1/
The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers (@roswellpark.bsky.social, @wilmotcancer.bsky.social) will face challenges, but “we’ll get through it”
https://cancerletter.com/podcastc/20250613_1/
Directors of two neighboring cancer centers (@roswellpark.bsky.social, @wilmotcancer.bsky.social) will face challenges, but “we’ll get through it”
https://cancerletter.com/podcastc/20250613_1/
June 13, 2025 at 10:21 PM
The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers (@roswellpark.bsky.social, @wilmotcancer.bsky.social) will face challenges, but “we’ll get through it”
https://cancerletter.com/podcastc/20250613_1/
Directors of two neighboring cancer centers (@roswellpark.bsky.social, @wilmotcancer.bsky.social) will face challenges, but “we’ll get through it”
https://cancerletter.com/podcastc/20250613_1/
In this week's issue of TCL, Gary Schwartz and Ramon Parsons focused on recent changes in the way the Cancer Center Support Grants are reviewed.
https://cancerletter.com/podcastc/20260130_1/
https://cancerletter.com/podcastc/20260130_1/
https://cancerletter.com/podcastc/20260130_1/
No description found
cancerletter.com
February 4, 2026 at 3:00 PM
In this week's issue of TCL, Gary Schwartz and Ramon Parsons focused on recent changes in the way the Cancer Center Support Grants are reviewed.
https://cancerletter.com/podcastc/20260130_1/
https://cancerletter.com/podcastc/20260130_1/
Raghu Kalluri (@utmbhealth.bsky.social): "People have seen how teams that play well together succeed in the end, winning a game—versus having one or two superstars. And I think that’s what comprehensive cancer care is."
https://cancerletter.com/podcastc/20260925_1/
https://cancerletter.com/podcastc/20260925_1/
The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Cancer Letter
What should a cancer center look like in an era of AI, genomics, complex patient populations, rising costs, and declinin
cancerletter.com
September 28, 2026 at 6:00 PM
Raghu Kalluri (@utmbhealth.bsky.social): "People have seen how teams that play well together succeed in the end, winning a game—versus having one or two superstars. And I think that’s what comprehensive cancer care is."
https://cancerletter.com/podcastc/20260925_1/
https://cancerletter.com/podcastc/20260925_1/
In a special episode of the new Cancer Letter Podcast, Suresh S. Ramalingam (@winshipatemory.bsky.social) moderates a panel of people who played a role in the discovery of the EGFR mutation in #LungCancer.
https://cancerletter.com/podcastc/20250214_5/
https://cancerletter.com/podcastc/20250214_5/
20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect - The Cancer Letter
Two decades ago, the discovery of the EGFR mutation transformed lung cancer treatment. The finding led to dramatically improved survival rates and ushered in the era of precision medicine and molecular profiling for lung cancer. In a special episode of the new Cancer Letter Podcast, Suresh S. Ramalingam, a lung cancer expert, executive director of […]
cancerletter.com
February 17, 2025 at 9:00 PM
In a special episode of the new Cancer Letter Podcast, Suresh S. Ramalingam (@winshipatemory.bsky.social) moderates a panel of people who played a role in the discovery of the EGFR mutation in #LungCancer.
https://cancerletter.com/podcastc/20250214_5/
https://cancerletter.com/podcastc/20250214_5/
Rather than treating the current revolution in science and medicine as a threat, Kalluri (@utmbhealth.bsky.social) and Miele (LSU-LCMC Health) see it as an opportunity to do more than just replicate existing models.
https://cancerletter.com/podcastc/20260925_1/
https://cancerletter.com/podcastc/20260925_1/
The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Cancer Letter
What should a cancer center look like in an era of AI, genomics, complex patient populations, rising costs, and declinin
cancerletter.com
September 26, 2026 at 12:00 PM
Rather than treating the current revolution in science and medicine as a threat, Kalluri (@utmbhealth.bsky.social) and Miele (LSU-LCMC Health) see it as an opportunity to do more than just replicate existing models.
https://cancerletter.com/podcastc/20260925_1/
https://cancerletter.com/podcastc/20260925_1/
The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it.
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish.
https://cancerletter.com/podcastc/20260925_1/
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish.
https://cancerletter.com/podcastc/20260925_1/
The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Cancer Letter
What should a cancer center look like in an era of AI, genomics, complex patient populations, rising costs, and declinin
cancerletter.com
September 25, 2026 at 9:32 PM
The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it.
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish.
https://cancerletter.com/podcastc/20260925_1/
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish.
https://cancerletter.com/podcastc/20260925_1/
New episode from NPR: Wait Wait... Don't Tell Me!: WWDTM: Ego Nwodim
This week, special guest Ego Nwodim joins panelists Tom Papa, Dulceé Sloan, and Hari Kondabolu
Learn more about sponsor message choices: podcastc...
Episode Download
This week, special guest Ego Nwodim joins panelists Tom Papa, Dulceé Sloan, and Hari Kondabolu
Learn more about sponsor message choices: podcastc...
Episode Download
May 24, 2025 at 7:06 AM
New episode from NPR: Wait Wait... Don't Tell Me!: WWDTM: Ego Nwodim
This week, special guest Ego Nwodim joins panelists Tom Papa, Dulceé Sloan, and Hari Kondabolu
Learn more about sponsor message choices: podcastc...
Episode Download
This week, special guest Ego Nwodim joins panelists Tom Papa, Dulceé Sloan, and Hari Kondabolu
Learn more about sponsor message choices: podcastc...
Episode Download
Lung cancer treatment was so dismal that @ramalingammd.bsky.social’s mentors discouraged him from entering the field. The discovery of the EGFR mutation changed all that.
https://cancerletter.com/podcastc/20250214_5/
https://cancerletter.com/podcastc/20250214_5/
20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect - The Cancer Letter
Two decades ago, the discovery of the EGFR mutation transformed lung cancer treatment. The finding led to dramatically improved survival rates and ushered in the era of precision medicine and molecular profiling for lung cancer. In a special episode of the new Cancer Letter Podcast, Suresh S. Ramalingam, a lung cancer expert, executive director of […]
cancerletter.com
February 19, 2025 at 3:00 PM
Lung cancer treatment was so dismal that @ramalingammd.bsky.social’s mentors discouraged him from entering the field. The discovery of the EGFR mutation changed all that.
https://cancerletter.com/podcastc/20250214_5/
https://cancerletter.com/podcastc/20250214_5/
Tom Lynch (@fredhutch.bsky.social) and Skip Burris (@scri.com) on how NIH funding cuts imperil biopharma innovation—and cost patient lives. In a time of uncertainty, “react to the knowns, not the fear”
https://cancerletter.com/podcastc/20250516_1/
https://cancerletter.com/podcastc/20250516_1/
The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives In a time of uncertainty, “react to the knowns, not the fear”...
Thomas J. Lynch Jr. and Howard A. “Skip” Burris III lead two institutions that couldn’t be more different—an NCI-designated Comprehensive Cancer Center on one side of the country and a for-profit research enterprise on the other—but they stay up at nights worrying about the same thing: “Changing the paradigm of how research is funded and […]
cancerletter.com
May 17, 2025 at 1:10 AM
Tom Lynch (@fredhutch.bsky.social) and Skip Burris (@scri.com) on how NIH funding cuts imperil biopharma innovation—and cost patient lives. In a time of uncertainty, “react to the knowns, not the fear”
https://cancerletter.com/podcastc/20250516_1/
https://cancerletter.com/podcastc/20250516_1/
Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer cancerletter.com/podcastc/202...
Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer - The Cancer Letter
Readers of The Cancer Letter and listeners of The Cancer Letter Podcast are familiar with the impact of President Donald Trump’s first nine months in office on the field of oncology. Now, the threats ...
cancerletter.com
September 20, 2025 at 2:00 PM
Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer cancerletter.com/podcastc/202...
In this episode of In the Headlines, Paul, Jacquelyn Cobb, and Claire Marie Porter, discuss the very public departure of Vinay Prasad from FDA following a snowballing of attacks on his political purity led by Laura Loomer.
https://cancerletter.com/podcastc/20250806-nih-prasad/
https://cancerletter.com/podcastc/20250806-nih-prasad/
August 6, 2025 at 5:13 PM
In this episode of In the Headlines, Paul, Jacquelyn Cobb, and Claire Marie Porter, discuss the very public departure of Vinay Prasad from FDA following a snowballing of attacks on his political purity led by Laura Loomer.
https://cancerletter.com/podcastc/20250806-nih-prasad/
https://cancerletter.com/podcastc/20250806-nih-prasad/
"We thought, ‘Oh my gosh, this can happen before Christmas. This is going to be our Christmas gift,'” @kidsvcancer.bsky.social's Goodman said. Instead, on Dec. 19, the Mikaela Naylon Give Kids a Chance Act was blocked in the Senate.
https://cancerletter.com/podcastc/20260107-goodman/
https://cancerletter.com/podcastc/20260107-goodman/
January 7, 2026 at 4:34 PM
"We thought, ‘Oh my gosh, this can happen before Christmas. This is going to be our Christmas gift,'” @kidsvcancer.bsky.social's Goodman said. Instead, on Dec. 19, the Mikaela Naylon Give Kids a Chance Act was blocked in the Senate.
https://cancerletter.com/podcastc/20260107-goodman/
https://cancerletter.com/podcastc/20260107-goodman/
🎙️ On the latest episode of The Directors podcast by @cancerletter.com, @ukmarkey.bsky.social's Dr. Mark Evers joins @rutgerscancer.bsky.social’s Dr. Steven Libutti to discuss the unique challenges facing cancer centers. Listen to the full podcast: cancerletter.com/podcastc/202...
The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not...
“I don’t think any good cancer center director would be worth their weight in salt if they weren’t worried about something at night,” said Mark Evers, director of University of Kentucky Markey Cancer ...
cancerletter.com
July 21, 2025 at 8:48 PM
🎙️ On the latest episode of The Directors podcast by @cancerletter.com, @ukmarkey.bsky.social's Dr. Mark Evers joins @rutgerscancer.bsky.social’s Dr. Steven Libutti to discuss the unique challenges facing cancer centers. Listen to the full podcast: cancerletter.com/podcastc/202...
On this week’s episode of The Cancer Letter Podcast, Sara Willa Ernst spoke with Jacquelyn Cobb, and Laurie McGinley, a former health and science editor at The Washington Post who is now on the board of Patient Action for Cancer Research.
https://cancerletter.com/podcastc/20251008-LaurieMcGinley/
https://cancerletter.com/podcastc/20251008-LaurieMcGinley/
October 8, 2025 at 6:37 PM
On this week’s episode of The Cancer Letter Podcast, Sara Willa Ernst spoke with Jacquelyn Cobb, and Laurie McGinley, a former health and science editor at The Washington Post who is now on the board of Patient Action for Cancer Research.
https://cancerletter.com/podcastc/20251008-LaurieMcGinley/
https://cancerletter.com/podcastc/20251008-LaurieMcGinley/
David Gius: "We want to translate from the bench to the bedside. We want to do drug discovery. We want to use AI as a way of interrogating how to use the new drugs that we are discovering and drugs that other people are using."
https://cancerletter.com/podcastc/20260807_1/
https://cancerletter.com/podcastc/20260807_1/
cancerletter.com
August 8, 2026 at 12:00 PM
David Gius: "We want to translate from the bench to the bedside. We want to do drug discovery. We want to use AI as a way of interrogating how to use the new drugs that we are discovering and drugs that other people are using."
https://cancerletter.com/podcastc/20260807_1/
https://cancerletter.com/podcastc/20260807_1/